Search
Search Results
-
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
Background and ObjectiveIn our outpatient pediatric and adult psychiatry centers, we reserve psychostimulants for predominantly inattentive attention...
-
Atomoxetine for suppression of vasovagal syncope
ObjectiveVasovagal syncope (VVS) is a common clinical condition with few effective medical therapies. The study aimed to evaluate the effectiveness...
-
Adis Summary of Research: Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
In patients with attention deficit hyperactivity disorder (ADHD), norepinephrine reuptake inhibitors like atomoxetine may show mild effectiveness in...
-
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together
Integrating CYP2D6 genotyping and therapeutic drug monitoring (TDM) is crucial for guiding individualized atomoxetine therapy in children with...
-
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence
PurposeThere is marked heterogeneity in treatment response of atomoxetine in patients with attention deficit/hyperactivity disorder (ADHD),...
-
Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
RationaleWorking memory deficits and associated neurofunctional abnormalities are frequently reported in attention-deficit/hyperactivity disorder...
-
Inhibitory effect of atomoxetine on Nav1.2 voltage-gated sodium channel currents
BackgroundAtomoxetine (ATX), a norepinephrine reuptake inhibitor (NRI), is used to attenuate the symptoms of Attention Deficit/Hyperactivity Disorder...
-
Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility
PurposePreliminary studies have shown a significant decrease in severity of obstructive sleep apnea (OSA) with the use of a combination of...
-
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite...
-
A novel spectrophotometric approach relies on a charge transfer complex between atomoxetine with quinone-based π-acceptor. Application to content uniformity test
Atomoxetine (ATO) belongs to psychoanaleptic drugs and is utilized in attention-deficit hyperactivity syndrome treatment. In this study, two facile...
